MEDANTA vs METROPOLIS: Stock Comparison
Head-to-head financial and trading comparison between Global Health Limited (MEDANTA) and Metropolis Healthcare Limited (METROPOLIS) in the Hospitals & Diagnostics sector.
MEDANTA
NSE: MEDANTAMETROPOLIS
NSE: METROPOLISKey Metrics Comparison Table
| Metric | MEDANTA | METROPOLIS | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹1,357.30 | ₹537.90 | — |
| 1-Year Price Return | +27.31% | +14.91% | MEDANTA (12.40% higher) |
| 52-Week High | ₹1,508.90 | ₹602.10 | — |
| 52-Week Low | ₹1,061.45 | ₹462.35 | — |
| 30-Day Annualized Volatility | 36.04% | 25.35% | METROPOLIS (Steadier) |
| 30-Day Average Daily Volume | 285,547 | 272,631 | MEDANTA (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between MEDANTA and METROPOLIS, which stock gave better returns over the last year?
MEDANTA has outperformed METROPOLIS over the past 12 months with a gain of 27.31% compared to 14.91%.
Which stock is less volatile: MEDANTA or METROPOLIS?
METROPOLIS demonstrated lower price volatility (25.35% annualized) compared to MEDANTA (36.04%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of MEDANTA vs METROPOLIS?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are MEDANTA and METROPOLIS direct sector competitors?
Yes, both companies operate within the Hospitals & Diagnostics sector in India and are actively tracked as sector peers by institutional and retail market participants.